Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Monitoring for hydroxychloroquine retinopathy.

Lotery A, Burdon M.

Eye (Lond). 2020 Feb 13. doi: 10.1038/s41433-020-0795-2. [Epub ahead of print] No abstract available.

PMID:
32055019
2.

Melanoma-associated retinopathy.

Elsheikh S, Gurney SP, Burdon MA.

Clin Exp Dermatol. 2020 Mar;45(2):147-152. doi: 10.1111/ced.14095. Epub 2019 Nov 19. Review.

PMID:
31742740
3.

End the postcode lottery for cataract surgery.

Burdon M.

BMJ. 2019 May 28;365:l2293. doi: 10.1136/bmj.l2293. No abstract available.

PMID:
31138535
4.

Detection of Papilloedema Study (DOPS): rates of false positive papilloedema in the community.

Blanch RJ, Horsburgh J, Creavin A; DOPS Study Group, Burdon MA, Williams C.

Eye (Lond). 2019 Jul;33(7):1073-1080. doi: 10.1038/s41433-019-0355-9. Epub 2019 Feb 20.

PMID:
30787443
5.

Bevacizumab: a new way of doing business. Part 2.

Lotery AJ, Burdon MA.

Eye (Lond). 2019 Apr;33(4):519-520. doi: 10.1038/s41433-018-0281-2. Epub 2018 Nov 27. No abstract available.

PMID:
30482906
6.

Biodiversity-function relationships in methanogenic communities.

Sierocinski P, Bayer F, Yvon-Durocher G, Burdon M, Großkopf T, Alston M, Swarbreck D, Hobbs PJ, Soyer OS, Buckling A.

Mol Ecol. 2018 Nov;27(22):4641-4651. doi: 10.1111/mec.14895. Epub 2018 Nov 22.

7.

Early Loss of Optic Cup with Increased Intracranial Pressure.

Horsburgh J, Bativala R, Burdon M, Shah P.

Neuroophthalmology. 2018 Jan 9;42(5):295-298. doi: 10.1080/01658107.2017.1405047. eCollection 2018 Oct.

8.

Idiopathic intracranial hypertension: consensus guidelines on management.

Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1088-1100. doi: 10.1136/jnnp-2017-317440. Epub 2018 Jun 14. Review.

9.

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary.

Yusuf IH, Foot B, Galloway J, Ardern-Jones MR, Watson SL, Yelf C, Burdon MA, Bishop PN, Lotery AJ.

Eye (Lond). 2018 Jul;32(7):1168-1173. doi: 10.1038/s41433-018-0136-x. Epub 2018 Jun 11. Review. No abstract available.

10.

The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report.

Rauz S, Koay SY, Foot B, Kaye SB, Figueiredo F, Burdon MA, Dancey E, Chandrasekar A, Lomas R.

Eye (Lond). 2017 Nov 17. doi: 10.1038/eye.2017.209. [Epub ahead of print] No abstract available.

PMID:
29148532
11.

The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary.

Rauz S, Koay SY, Foot B, Kaye SB, Figueiredo F, Burdon MA, Dancey E, Chandrasekar A, Lomas R.

Eye (Lond). 2018 Jan;32(1):44-48. doi: 10.1038/eye.2017.208. Epub 2017 Nov 17. Review. No abstract available.

12.

Weighing the Risks and Benefits of Antidepressants in Idiopathic Intracranial Hypertension.

Gruener AM, Jolly AD, Ellison JMA, Burdon MA.

J Neuroophthalmol. 2018 Mar;38(1):128-129. doi: 10.1097/WNO.0000000000000595. No abstract available.

PMID:
29135815
13.

Development and validation of a questionnaire assessing the quality of life impact of Colour Blindness (CBQoL).

Barry JA, Mollan S, Burdon MA, Jenkins M, Denniston AK.

BMC Ophthalmol. 2017 Oct 2;17(1):179. doi: 10.1186/s12886-017-0579-z.

14.

Balancing Self-Tracking and Surveillance: Legal, Ethical and Technological Issues in Using Smartphones to Monitor Communication in People with Health Conditions.

Liddle J, Burdon M, Ireland D, Carter A, Knuepffer C, Milevskiy N, McBride S, Chenery H, Hall W.

J Law Med. 2016;24(2):387-97.

PMID:
30137711
15.

Treating idiopathic intracranial hypertension.

Mollan SP, Burdon MA, Sinclair AJ.

JAMA Neurol. 2014 Oct;71(10):1326-7. doi: 10.1001/jamaneurol.2014.2360. No abstract available.

PMID:
25322316
16.

Aspirin as adjunctive treatment for giant cell arteritis.

Mollan SP, Sharrack N, Burdon MA, Denniston AK.

Cochrane Database Syst Rev. 2014 Aug 3;(8):CD010453. doi: 10.1002/14651858.CD010453.pub2. Review.

PMID:
25087045
17.

A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension.

Mollan SP, Markey KA, Benzimra JD, Jacks A, Matthews TD, Burdon MA, Sinclair AJ.

Pract Neurol. 2014 Dec;14(6):380-90. doi: 10.1136/practneurol-2014-000821. Epub 2014 May 8. Review.

18.

Detection of branch retinal artery occlusions in Susac's syndrome.

Boukouvala S, Jacob S, Lane M, Denniston AK, Burdon MA.

BMC Res Notes. 2014 Jan 21;7:56. doi: 10.1186/1756-0500-7-56.

19.

Comment on 'Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm'.

Mollan S, Lee S, Senthil L, Burdon M.

Eye (Lond). 2013 Dec;27(12):1423-4. doi: 10.1038/eye.2013.198. Epub 2013 Sep 20. No abstract available.

20.

Assessment of pumped mercury vapour adsorption tubes as passive samplers using a micro-exposure chamber.

Brown RJ, Burdon MK, Brown AS, Kim KH.

J Environ Monit. 2012 Sep;14(9):2456-63. doi: 10.1039/c2em30101f. Epub 2012 Jul 27.

PMID:
22842560
21.

Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension.

Sinclair AJ, Burdon MA, Nightingale PG, Matthews TD, Jacks A, Lawden M, Sivaguru A, Gaskin BJ, Rauz S, Clarke CE, Ball AK.

J Neurol. 2012 Jul;259(7):1406-12. doi: 10.1007/s00415-011-6365-6. Epub 2012 Jan 12.

PMID:
22237821
22.

Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review.

Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G.

Cephalalgia. 2011 Dec;31(16):1627-33. doi: 10.1177/0333102411423305. Epub 2011 Oct 3.

PMID:
21968519
23.

A randomised controlled trial of treatment for idiopathic intracranial hypertension.

Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies MB, Sinclair AJ, Clarke CE.

J Neurol. 2011 May;258(5):874-81. doi: 10.1007/s00415-010-5861-4. Epub 2010 Dec 16.

PMID:
21161260
25.

Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?

Sinclair AJ, Walker EA, Burdon MA, van Beek AP, Kema IP, Hughes BA, Murray PI, Nightingale PG, Stewart PM, Rauz S, Tomlinson JW.

J Clin Endocrinol Metab. 2010 Dec;95(12):5348-56. doi: 10.1210/jc.2010-0729. Epub 2010 Sep 8.

PMID:
20826586
26.

Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S.

BMJ. 2010 Jul 7;341:c2701. doi: 10.1136/bmj.c2701.

27.

NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases--a diagnostic tool?

Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, Rauz S, Young SP.

NMR Biomed. 2010 Feb;23(2):123-32. doi: 10.1002/nbm.1428.

PMID:
19691132
28.

Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management.

Mollan SP, Ball AK, Sinclair AJ, Madill SA, Clarke CE, Jacks AS, Burdon MA, Matthews TD.

Eur Neurol. 2009;62(2):105-8. doi: 10.1159/000222781. Epub 2009 Jun 12.

PMID:
19521086
29.

Intracranial dermoid cyst presenting as an isolated fourth nerve palsy.

Tailor R, Mollan SP, Burdon MA.

J Neurol. 2009 May;256(5):820-1. doi: 10.1007/s00415-009-5002-0. Epub 2009 Feb 25. No abstract available.

PMID:
19240965
30.

Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance?

Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, Stewart PM, Nightingale PG, Clarke CE, Rauz S.

Clin Endocrinol (Oxf). 2009 Jun;70(6):863-9. doi: 10.1111/j.1365-2265.2008.03401.x. Epub 2008 Sep 2.

PMID:
18771566
31.

Exploring the pathogenesis of IIH: an inflammatory perspective.

Sinclair AJ, Ball AK, Burdon MA, Clarke CE, Stewart PM, Curnow SJ, Rauz S.

J Neuroimmunol. 2008 Sep 15;201-202:212-20. doi: 10.1016/j.jneuroim.2008.06.029. Epub 2008 Aug 3. Review.

PMID:
18676028
32.

Aetiology and outcomes of adult superior oblique palsies: a modern series.

Mollan SP, Edwards JH, Price A, Abbott J, Burdon MA.

Eye (Lond). 2009 Mar;23(3):640-4. doi: 10.1038/eye.2008.24. Epub 2008 Mar 7. Review.

PMID:
18327160
33.

Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus.

Sinclair AJ, Onyimba CU, Khosla P, Vijapurapu N, Tomlinson JW, Burdon MA, Stewart PM, Murray PI, Walker EA, Rauz S.

J Neuroendocrinol. 2007 Aug;19(8):614-20.

PMID:
17620103
34.

Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency.

Clarke CE, Alger S, Preece MA, Burdon MA, Chavda S, Denis S, Ferdinandusse S, Wanders RJ.

Neurology. 2004 Jul 13;63(1):188-9. Review. No abstract available.

PMID:
15249642
35.

Superior oblique myokymia improved with gabapentin.

Deokule S, Burdon M, Matthews T.

J Neuroophthalmol. 2004 Mar;24(1):95-6. No abstract available.

PMID:
15206450
36.

Visual field loss and Alzheimer's disease.

Whittaker KW, Burdon MA, Shah P.

Eye (Lond). 2002 Mar;16(2):206-8. No abstract available.

37.

Wilson's disease presenting in a family with an apparent dominant history of tremor.

Nicholl DJ, Ferenci P, Polli C, Burdon MB, Pall HS.

J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):514-6.

38.

Multiple sclerosis presenting with debilitating Uhthoff's symptom.

Fitt AW, Burdon MA.

Eye (Lond). 1999 Oct;13 ( Pt 5):669-70. No abstract available.

PMID:
10696325
39.

Dominant optic atrophy. Refining the clinical diagnostic criteria in light of genetic linkage studies.

Johnston RL, Seller MJ, Behnam JT, Burdon MA, Spalton DJ.

Ophthalmology. 1999 Jan;106(1):123-8.

PMID:
9917792
40.

Linkage studies in dominant optic atrophy, Kjer type: possible evidence for heterogeneity.

Seller MJ, Behnam JT, Lewis CM, Johnston RL, Burdon MA, Spalton DJ.

J Med Genet. 1997 Dec;34(12):967-72.

41.

Dominant optic atrophy, Kjer type. Linkage analysis and clinical features in a large British pedigree.

Johnston RL, Burdon MA, Spalton DJ, Bryant SP, Behnam JT, Seller MJ.

Arch Ophthalmol. 1997 Jan;115(1):100-3. Erratum in: Arch Ophthalmol 1997 May;115(5):681.

PMID:
9006433
42.

The retina.

Burdon MA, Sanders MD.

Curr Opin Neurol. 1996 Feb;9(1):16-20. Review.

PMID:
8722658
43.

Comparison of pars plana vitrectomy and scleral buckling for uncomplicated rhegmatogenous retinal detachment.

Woon WH, Burdon MA, Green WT, Chignell AH.

Curr Opin Ophthalmol. 1995 Jun;6(3):76-9. Review.

PMID:
10150874
44.

A survey of corneal graft practice in the United Kingdom.

Burdon MA, McDonnell P.

Eye (Lond). 1995;9 ( Pt 6 Su):6-12.

PMID:
8729012
45.

Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome.

Buckley SA, Reeves B, Burdon M, Moorman C, Wheatcroft S, Edelsten C, Benjamin L.

Br J Ophthalmol. 1994 Jul;78(7):529-33.

46.

Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy.

Tsaloumas MD, Good PA, Burdon MA, Misson GP.

Eye (Lond). 1994;8 ( Pt 6):638-45.

PMID:
7867819
47.

Dissociated eye movements in craniosynostosis: a hypothesis revived.

Cheng H, Burdon MA, Shun-Shin GA, Czypionka S.

Br J Ophthalmol. 1993 Sep;77(9):563-8.

48.

Isolation and detection of urease genes in Ureaplasma urealyticum.

Willoughby JJ, Russell WC, Thirkell D, Burdon MG.

Infect Immun. 1991 Jul;59(7):2463-9.

49.

Response to dynamic exercise in cardiac transplant recipients: implications for control of the sodium regulatory hormone atrial natriuretic peptide.

Singer DR, Banner NR, Cox A, Patel N, Burdon M, Buckley MG, MacGregor GA, Yacoub MH.

Clin Sci (Lond). 1990 Feb;78(2):159-63.

PMID:
2155742
50.

The urease of Ureaplasma urealyticum.

Thirkell D, Myles AD, Precious BL, Frost JS, Woodall JC, Burdon MG, Russell WC.

J Gen Microbiol. 1989 Feb;135(Pt 2):315-23.

PMID:
2482331

Supplemental Content

Loading ...
Support Center